Prevalence and association of atherosclerosis at three different arterial sites in patients with type III hyperlipoproteinemia

被引:14
作者
Dobmeyer, J [1 ]
Lohrmann, J [1 ]
Feussner, G [1 ]
机构
[1] UNIV HEIDELBERG,DEPT INTERNAL MED ENDOCRINOL & METAB 1,D-69115 HEIDELBERG,GERMANY
关键词
apolipoprotein E; atherosclerosis; dysbetalipoproteinemia; type III hyperlipoproteinemia;
D O I
10.1016/0021-9150(95)05633-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have examined the prevalence of clinically significant atherosclerosis in 78 patients with type III hyperlipoproteinemia (HLP) and homozygosity for apolipoprotein (apo) E2. Forty-six of these individuals (59%) had no atherosclerosis, 32 patients (41%) had atherosclerosis, i.e., atherosclerosis of the extracranial carotid arteries (CAA), coronary arteries (CAD) or/and peripheral arteries of the legs (PVD), either singly or in combination. No association could be shown with respect to the co-prevalence of atherosclerotic lesions at these different arterial sites, except for the high predictive value (pv=0.88, P=0.006) of CAA for the presence of PVD. Hence, documentation of atherosclerosis under clinical aspects at one of these exposed arterial territories does not allow a reliable prediction of generalised atherosclerosis or local atherosclerosis at other sites of the arterial tree in individuals with this familial lipoprotein disorder. Therefore, assessment of the extent of clinically significant atherosclerosis in type III HLP patients should include careful and thorough examination of the extracranial carotid arteries, the coronary arteries, and the peripheral arteries of the legs.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 43 条
  • [1] BERGLUND GL, 1994, J INTERN MED, V236, P549
  • [2] NONINVASIVE ASSESSMENT OF ATHEROSCLEROSIS
    BLANKENHORN, DH
    ROONEY, JA
    CURRY, PJ
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1984, 26 (04) : 295 - 307
  • [3] RISK-FACTORS FOR EARLY CAROTID ATHEROSCLEROSIS IN MIDDLE-AGED FRENCH WOMEN
    BONITHONKOPP, C
    SCARABIN, PY
    TAQUET, A
    TOUBOUL, PJ
    MALMEJAC, A
    GUIZE, L
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (04): : 966 - 972
  • [4] TYPE-III HYPERLIPOPROTEINEMIA - DIAGNOSIS, MOLECULAR DEFECTS, PATHOLOGY, AND TREATMENT
    BREWER, HB
    ZECH, LA
    GREGG, RE
    SCHWARTZ, D
    SCHAEFER, EJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1983, 98 (05) : 623 - 640
  • [5] LIPOPROTEIN METABOLISM IN THE MACROPHAGE - IMPLICATIONS FOR CHOLESTEROL DEPOSITION IN ATHEROSCLEROSIS
    BROWN, MS
    GOLDSTEIN, JL
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 : 223 - 261
  • [6] THE RELATION OF LIPOPROTEIN[A] CONCENTRATIONS AND APOLIPOPROTEIN[A] PHENOTYPES WITH ASYMPTOMATIC ATHEROSCLEROSIS IN SUBJECTS OF THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY
    BROWN, SA
    MORRISETT, JD
    BOERWINKLE, E
    HUTCHINSON, R
    PATSCH, W
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (11): : 1558 - 1566
  • [7] CAROTID STENOSIS IS A POWERFUL PREDICTOR OF A POSITIVE EXERCISE ELECTROCARDIOGRAM IN A LARGE HYPERLIPIDEMIC POPULATION
    BRUCKERT, E
    GIRAL, P
    SALLOUM, J
    KAHN, JF
    DAIROU, F
    TRUFFERT, J
    REVERDY, V
    THOMAS, D
    EVANS, J
    GROSGOGEAT, Y
    DEGENNES, JL
    [J]. ATHEROSCLEROSIS, 1992, 92 (2-3) : 105 - 114
  • [8] Conover W. J., 1980, Practical nonparametric statistics, V2nd
  • [9] EVALUATION OF THE ASSOCIATIONS BETWEEN CAROTID-ARTERY ATHEROSCLEROSIS AND CORONARY-ARTERY STENOSIS - A CASE-CONTROL STUDY
    CRAVEN, TE
    RYU, JE
    ESPELAND, MA
    KAHL, FR
    MCKINNEY, WM
    TOOLE, JF
    MCMAHAN, MR
    THOMPSON, CJ
    HEISS, G
    CROUSE, JR
    [J]. CIRCULATION, 1990, 82 (04) : 1230 - 1242
  • [10] APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS
    DAVIGNON, J
    GREGG, RE
    SING, CF
    [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 1 - 21